A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial

STUDY OBJECTIVE: A safe alternative to erythropoiesis‐stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by...

Descripción completa

Detalles Bibliográficos
Autores principales: Birgegård, Gunnar, Henry, David, Glaspy, John, Chopra, Rakesh, Thomsen, Lars L., Auerbach, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071650/
https://www.ncbi.nlm.nih.gov/pubmed/26927900
http://dx.doi.org/10.1002/phar.1729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071650/
https://www.ncbi.nlm.nih.gov/pubmed/26927900
http://dx.doi.org/10.1002/phar.1729

Ejemplares similares